NCT03311750 - Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 26, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

May 20, 2021

Conditions

Advanced Colorectal Cancer

Interventions

DRUG

Panitumumab

6 mg/Kg will be administered intravenous over 1 hour on Day 1 every 2 weeks or 9 mg/Kg every 3 weeks.

Trial Locations (8)

Bank Of Cyprus Oncology Centre, Stróvolos

"Attikon University Hospital", Chaïdári

Agii Anargiri Cancer Hospital, Athens

Metropolitan Hospital, Athens

University Hospital of Patra, Rio

Ioannina University Hospital, Ioannina

Euromedica General Clinic of Thessaloniki, Thessaloniki

University Hospital of Heraklion, Heraklion